‘Make Motherhood Great Again’: Pronatalism Finds a Comfortable Home in the Trump Administration
By Shoshanna Ehrlich,
Ms. Magazine
| 04. 15. 2025
Promotional image from Natalism.org
A month into President Donald Trump’s second term, Sean Duffy, the newly appointed secretary of the Department of Transportation (DOT), issued a memo declaring that “DOT-supported or assisted state contracts shall prioritize projects and goals … that give preference to communities with marriage and birth rates higher than the national average.” This move by Duffy—who happens to be a father of seven—tying federal transportation spending to birth and marriage rates was characterized as “disturbingly dystopian” by Sen. Patty Murray (D-Wash.) and “deeply frightening” by Sen. Richard Blumenthal (D-Conn.).
Duffy’s directive embraces pronatalism—a once-fringe right-wing ideology that has found a comfortable home in the current administration. (Vice President JD Vance, President Donald Trump and Elon Musk have around 22 kids between them.) Pronatalists believe that having lots of children is an urgent social project—at least for those living in the United States and Europe—in order to “maintain population levels, support economic growth, and preserve cultural and national identities.” And although not usually mentioned in the same breath, pronatalism fits cozily aside the Trump...
Related Articles
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...
By Ben Fidler and Ned Pagliarulo, Biopharma Dive | 07.21.2025
One month ago, a 51-year-old man treated in a clinical trial with an experimental gene therapy became dangerously sick. The developer of that treatment, Sarepta Therapeutics, informed the Food and Drug Administration his case could be life-threatening.
The man died...
By Pat Duggins, Alabama Public Radio | 06.27.2025
PAT DUGGINS-- If I were to say, ‘man, have you seen the price of eggs these days?’ You're probably thinking, Oh, he's talking about inflation and the price of groceries and how it became an issue in the presidential race...